Story thread · 2 reports / 2 sources

Tyra Biosciences prices $400 million stock offering

investing.com · 23h · first report

The coverage

  1. Tyra Biosciences prices $400 million equity offering to fund dabogratinib development and other programs

    seekingalpha.com · 23h

The conversation · 0

Sign in to join the conversation.

No comments yet — start the thread.